These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1842377)

  • 1. Adenosquamous carcinoma of the prostate: a case report.
    Devaney DM; Dorman A; Leader M
    Hum Pathol; 1991 Oct; 22(10):1046-50. PubMed ID: 1842377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosquamous carcinoma of prostate.
    Accetta PA; Gardner WA
    Urology; 1983 Jul; 22(1):73-5. PubMed ID: 6346632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosquamous carcinoma of the prostate: case report with DNA analysis, immunohistochemistry, and literature review.
    Bassler TJ; Orozco R; Bassler IC; Boyle LM; Bormes T
    Urology; 1999 Apr; 53(4):832-4. PubMed ID: 10197870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bilateral breast metastases from oat-cell lung carcinoma in a man treated with diethylstilbestrol for prostatic adenocarcinoma.
    Giarelli L; Ferlito A
    J Am Geriatr Soc; 1976 Nov; 24(11):511-5. PubMed ID: 184140
    [No Abstract]   [Full Text] [Related]  

  • 5. Adenosquamous carcinoma of the prostate.
    Saito R; Davis BK; Ollapally EP
    Hum Pathol; 1984 Jan; 15(1):87-9. PubMed ID: 6319269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of immunohistochemistry in metastatic prostatic adenocarcinoma to the breast.
    Green LK; Klima M
    Hum Pathol; 1991 Mar; 22(3):242-6. PubMed ID: 1706305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Squamous cell carcinoma at the prostatectomy site: squamous differentiation of recurrent prostate carcinoma.
    Rahmanou F; Koo J; Marinbakh AY; Solliday MP; Grob BM; Chin NW
    Urology; 1999 Oct; 54(4):744. PubMed ID: 10754146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Squamous metastases from prostatic adenocarcinoma.
    Accetta PA; Gardner WA
    Prostate; 1982; 3(5):515-21. PubMed ID: 6755409
    [No Abstract]   [Full Text] [Related]  

  • 9. Adenosquamous carcinoma of the prostate.
    Gattuso P; Carson HJ; Candel A; Castelli MJ
    Hum Pathol; 1995 Jan; 26(1):123-6. PubMed ID: 7821910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rare and unusual histological variants of prostatic carcinoma: clinical significance.
    Mazzucchelli R; Lopez-Beltran A; Cheng L; Scarpelli M; Kirkali Z; Montironi R
    BJU Int; 2008 Nov; 102(10):1369-74. PubMed ID: 18793296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intermittent androgen suppression on androgen-dependent tumors. Apoptosis and serum prostate-specific antigen.
    Akakura K; Bruchovsky N; Goldenberg SL; Rennie PS; Buckley AR; Sullivan LD
    Cancer; 1993 May; 71(9):2782-90. PubMed ID: 7682149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Squamous cell carcinoma of the prostate: a transformation from adenocarcinoma after the use of a luteinizing hormone-releasing hormone agonist and flutamide.
    Braslis KG; Davi RC; Nelson E; Civantos F; Soloway MS
    Urology; 1995 Feb; 45(2):329-31. PubMed ID: 7855985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Association of prostatic adenocarcinoma with transitional cell and squamous cell carcinomas of the same organ].
    Samsonov VA; Kolomoĭtsev SV
    Arkh Patol; 1983; 45(2):28-34. PubMed ID: 6847410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA ploidy pattern of each carcinomatous component in adenosquamous lung carcinoma.
    Ichinose Y; Hara N; Takamori S; Maeda K; Yano T; Ohta M
    Ann Thorac Surg; 1993 Mar; 55(3):593-6. PubMed ID: 8452418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple primary malignant neoplasms.
    Lee SS; Wasiljew BK; Song KT
    J Surg Oncol; 1984 Jan; 25(1):44-7. PubMed ID: 6694392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obstructive jaundice associated with carcinoma of the prostate.
    Ben-Ishay D; Slavin S; Levij IS; Eliakim M
    Isr J Med Sci; 1975 Aug; 11(8):838-44. PubMed ID: 1165179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Histologic variants of prostate cancer].
    Cheng L; Xu JW; Teng XD
    Zhonghua Bing Li Xue Za Zhi; 2009 Jul; 38(7):495-8. PubMed ID: 19781207
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of pathologic variables and hormonal treatment after radical prostatectomy for stage D1 disease.
    Zincke H
    Oncology (Williston Park); 1991 Mar; 5(3):129-39; discussion 139-40, 142. PubMed ID: 1829940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Squamous cell carcinoma of the prostate.
    Mohan H; Bal A; Punia RP; Bawa AS
    Int J Urol; 2003 Feb; 10(2):114-6. PubMed ID: 12588611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transformation of prostatic adenocarcinoma to well-differentiated neuroendocrine tumor after hormonal treatment.
    Gilani S; Guo CC; Li-Ning EM; Pettaway C; Troncoso P
    Hum Pathol; 2017 Jun; 64():186-190. PubMed ID: 28159676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.